Opinion

Beyond Surface Monitoring: Understanding chemical, vertical and health dimensions of air pollution in India

Air pollution is often discussed in terms of numbers: particulate matter concentrations, Air Quality Index (AQ...

17 November, 2026 | Tuesday | Views

Medtech

image credit- shutterstock
Centre invites new applications under incentive scheme for production of medical devices

The central government has invited new applications under the Production-Linked Incentive Scheme to promote do...

11 November, 2026 | Wednesday | News

Start-Ups

image credit- freepik
BTS 2026 puts India's biotech startups and research institutions in focus

India's biotechnology innovation ecosystem will receive a dedicated platform at Bengaluru Tech Summit 2026, wi...

17 November, 2026 | Tuesday | News

Inside Magazine

INDIA 2030: WHO SUPPLIES THE NEXT 10 MILLION?

India’s diabetes market is entering a defining decade. The withdrawal of selected human insulin pens by Novo Nordisk, the arrival of once-weekly insulin, the rapid expansion of generic semaglutide and the growing adoption of glucose-monitoring technologies are reshaping competition. As pharmaceutical companies and technology providers reposition themselves, the market is splitting into four distinct territories: mass-market insulin, premium insulin, diabetes technology and therapies that may delay insulin initiation. This cover story examines the companies, strategies and innovations shaping the next phase of growth—and asks whether market expansion will translate into better, more affordable diabetes care for millions of Indians.

For Feedback, please email us at: communications@mmactiv.com

Sign up here to access BioSpectrum India Flip Book

Videos

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy